《JAMA,6月15日,Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-06-16
  • Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

    Deborah Steensels, PharmD, PhD1; Els Oris, MD1; Laura Coninx, MSc, PhD1; et al Dieter Nuyens, MD, PhD1; Marie-Luce Delforge, MD, PhD2; Pieter Vermeersch, MD, PhD3; Line Heylen, MD, PhD1,4

    Author Affiliations Article Information

    JAMA. Published online June 15, 2020. doi:10.1001/jama.2020.11160

    Belgium has a high burden of coronavirus disease 2019 (COVID-19), especially the region surrounding the Hospital East-Limburg, a tertiary care center.1 Infection prevention measures were instituted in the hospital beginning March 4, 2020, including testing and contact tracing of all symptomatic patients and staff, changes in hospital operations, and provision of personal protective equipment (PPE). The first case was detected March 13 (Figure 1). We investigated the prevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among hospital staff.

  • 原文来源:https://jamanetwork.com/journals/jama/fullarticle/2767382?resultClick=1
相关报告
  • 《6月15日_比利时东林堡总医院3056名员工SARS-CoV-2抗体筛查结果分析》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-19
    • 信息名称:比利时东林堡总医院3056名员工SARS-CoV-2抗体筛查结果分析 1.时间:2020年6月15日 2.机构或团队:比利时东林堡总医院、布鲁塞尔自由大学、鲁汶大学医院、哈瑟尔特大学 3.事件概要: 比利时东林堡总医院等于6月15日在JAMA上发表题为“Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium”的文章,调查了比利时东林堡总医院工作人员中SARS-CoV-2抗体的情况。文章指出,2020年4月22日至2020年4月30日,对该医院的所有工作人员(包括临床和非临床工作人员及志愿者)进行血清学检测;有症状的工作人员被隔离,不进行检测。文章结果显示,该医院4125名员工中有3056人参与检测;在没有接受检测的人员中,至少有三分之一是在此期间没有上班的人员;共检测到197名员工有SARS-CoV-2的IgG抗体;年龄和性别在有无抗体的员工中没有显著的统计学差异;参与临床护理、在封锁期间工作过、参与过COVID-19患者的护理以及接触过COVID-19阳性同事的情况与血清阳性率无统计学相关;相反,接触疑似或确诊的COVID-19家庭成员与抗体阳性率相关。作者指出,该研究显示,直接参与临床护理或在COVID-19诊疗科室工作都不会增加血清阳性的几率,而有疑似COVID-19家庭接触者则会增加几率。个人防护用品的高可用性、高标准的感染预防措施、对有症状工作人员的PCR筛查,以及接触者追踪和隔离,可能是血清阳性率相对较低的原因。 4.附件: 原文链接: https://jamanetwork.com/journals/jama/fullarticle/2767382?resultClick=1
  • 《JAMA,6月8日,Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-09
    • Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 Elizabeth Whittaker, MD1,2; Alasdair Bamford, MD3,4; Julia Kenny, MD5,6; et alMyrsini Kaforou, PhD2; Christine E. Jones, MD7; Priyen Shah, MD2; Padmanabhan Ramnarayan, MD1,8; Alain Fraisse, MD9; Owen Miller, MD10,11; Patrick Davies, MD12; Filip Kucera, MD13; Joe Brierley, MD14; Marilyn McDougall, MD6,15; Michael Carter, MD6,15; Adriana Tremoulet, MD16; Chisato Shimizu, MD16; Jethro Herberg, MD1,2; Jane C. Burns, MD16; Hermione Lyall, MD1; Michael Levin, MD2; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia Author Affiliations Article Information JAMA. Published online June 8, 2020. doi:10.1001/jama.2020.10369 Abstract Importance  In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome of fever and inflammation. Objectives  To describe the clinical and laboratory characteristics of hospitalized children who met criteria for the pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PIMS-TS) and compare these characteristics with other pediatric inflammatory disorders. Design, Setting, and Participants  Case series of 58 children from 8 hospitals in England admitted between March 23 and May 16, 2020, with persistent fever and laboratory evidence of inflammation meeting published definitions for PIMS-TS. The final date of follow-up was May 22, 2020. Clinical and laboratory characteristics were abstracted by medical record review, and were compared with clinical characteristics of patients with Kawasaki disease (KD) (n = 1132), KD shock syndrome (n = 45), and toxic shock syndrome (n = 37) who had been admitted to hospitals in Europe and the US from 2002 to 2019.